Published in Women's Health Weekly, February 17th, 2005
Study 1: Researchers with the Montreal General Hospital reported in 1998 "that a significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor specific germline mutations in BRCA1 or BRCA2 attributed to common founders."
Now, in a paper in the International Journal of Cancer, the team has determined "the frequency of previously described mutations (n=7) and 13 mutations identified in French Canadian families since 1998, in a new group of families (n=88)."
K.K. Oros and colleagues reported, "Four of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly